Based on these findings, along with the elevated serum VEGF-D levels which are highly specific for LAM, we decided not to perform additional tests such as tumor marker analysis or positron emission tomography (PET)-CT scans. Here, VEGFD is linked to lymphangioleiomyomatosis.